CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 277 filers reported holding CLOVIS ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $551,000 | -18.0% | 140,226 | +210.4% | 0.01% | -47.4% |
| Q2 2019 | $672,000 | -97.0% | 45,175 | -81.0% | 0.02% | -96.6% |
| Q2 2017 | $22,249,000 | +15.4% | 237,631 | -21.5% | 0.55% | +17.9% |
| Q1 2017 | $19,272,000 | +136.2% | 302,689 | +64.8% | 0.47% | +168.6% |
| Q4 2016 | $8,160,000 | +31.3% | 183,693 | +171.9% | 0.18% | -40.1% |
| Q3 2015 | $6,213,000 | – | 67,559 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |